Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody
Open Access
- 29 January 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 113 (5), 1062-1070
- https://doi.org/10.1182/blood-2008-07-168146
Abstract
Veltuzumab is a humanized anti-CD20 monoclonal antibody with complementarity-determining regions (CDRs) identical to rituximab, except for one residuThis publication has 30 references indexed in Scilit:
- Newer monoclonal antibodies for hematological malignanciesExperimental Hematology, 2008
- First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trialBlood, 2008
- Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptideMolecular Immunology, 2008
- Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 studyBlood, 2008
- Mechanisms of killing by anti-CD20 monoclonal antibodiesMolecular Immunology, 2007
- Evaluation of the Binding of Radiolabeled Rituximab to CD20-Positive Lymphoma Cells: AnIn VitroFeasibility Study Concerning Low-Dose-Rate Radioimmunotherapy with theα-Emitter227ThCancer Biotherapy & Radiopharmaceuticals, 2007
- Follicular NHL: From Antibodies and Vaccines to Graft-versus-Lymphoma EffectsHematology, 2007
- Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursorBlood, 2006
- Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomasBlood, 2004
- Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s LymphomaClinical Cancer Research, 2004